Aegerion Pharma (AEGR) Surges on Japanese Approval of JUXTAPID

September 28, 2016 4:45 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Aegerion Pharma (NASDAQ: AEGR) is gaining 33% after-hours after the company announced that Japans Ministry of Health, Labor & Welfare (MHLW) has approved JUXTAPID for patients with homozygous familial hypercholesterolemia (HoFH).

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

FDA, Momentum Movers, Trader Talk

Add Your Comment